FUNCTIONAL GI DISORDERS
INTRODUCTION
Fermentation of unabsorbed carbohydrates by colonic anaerobic microfl ora produces hydrogen (H 2 ), carbondioxide (CO 2 ), methane (CH 4 ), as well as short chain fatty acids and sulfi tes (1) . A variable proportion of H 2 and CH 4 are absorbed, transported to the lungs and exhaled through breath, and the rest expelled in fl atus (1) . Methane gas is produced by enteric bacteria in 30 -62 % of healthy humans (1 -6) .
For many years, methane was thought to be physiologically inert. However, there is increasing evidence from clinical and epidemiological studies that methanogenesis may be associated with changes in gut physiology. Methane production in healthy humans has been shown to inversely correlate with stool frequency and colonic transit (4) . Children with constipation and soiling have higher prevalence of methanogenic fl ora and relatively slower colonic transit (7) . Likewise, patients with irritable bowel syndrome (IBS) and methane production (aft er a lactulose load) were reported to invariably have IBS-C (8, 9) . Furthermore, the degree of methane production during a lactulose breath test was reported to correlate with the degree of constipation in IBS subjects (10) .
Th ere is some evidence from animal experiments that methane may have eff ects on small bowel and colonic motility. Recently, About 35 % of humans have methane-producing gut fl ora. Methane-producing irritable bowel syndrome (IBS) subjects are generally constipated. In animal models, methane infusion slows intestinal transit. Whether methanogenic fl ora alters colonic transit or stool characteristics and its relationship to constipation is unclear. The aim of this study was to examine the prevalence and association of methanogenic fl ora in patients with slow transit (ST) constipation and normal transit (NT) constipation and non-constipated controls.
METHODS:
Ninety-six consecutive subjects with chronic constipation (CC) (Rome III) were evaluated with radioopaque marker (ROM) transit studies and were classifi ed as ST (>20 % ROM retention) or NT. All constipated subjects and 106 non-constipated controls underwent breath tests to assess methane production. Baseline CH 4 of ≥ 3 p.p.m. was used to defi ne presence of methanogenic fl ora. Stool frequency and consistency were assessed using a prospective stool diary. Correlation analyses were performed.
RESULTS:
Forty-eight subjects had ST and 48 had NT. Prevalence of methanogenic fl ora was higher ( P < 0.05) in ST (75 % ) compared to NT (44 % ) or controls (28 % ). ST patients had higher methane production compared to NT and controls ( P < 0.05). NT patients also produced more methane compared to controls ( P < 0.05). There was moderate( P < 0.05) correlation among baseline, peak, and area under the curve (AUC) of methane response with colonic transit but not with stool characteristics.
FUNCTIONAL GI DISORDERS
methane has been shown to increase non-propagating small bowel contractile activity and decrease small bowel transit in animal models (11) . Th e aforementioned studies suggest an association between the degree of methane production and alterations in stool frequency in both healthy humans and subjects with IBS. However, the prevalence of methanogenic fl ora in non-IBS chronic constipation (CC) and its eff ect on colonic transit and stool characteristics have not been assessed. We hypothesized that subjects with CC have higher prevalence of methanogenic fl ora when compared with non-constipated controls and methane production in response to a carbohydrate substrate correlated with colonic transit.
Th erefore, our aims were (i) to evaluate the prevalence of methanogenic fl ora in subjects with CC and its pathophysiologic subtypes and compare this with non-constipated controls; (ii) to examine the correlation among methane production, colonic transit, and stool characteristics in subjects with and without constipation.
METHODS

Subjects
We examined consecutive subjects with CC (Rome III) who were referred to a tertiary care center (12) . We excluded patients with severe cardiovascular disease, chronic renal failure, neurologic diseases, recent use of antibiotics ( < 6 weeks), or those with previous gastrointestinal surgery. Patients with alternating constipation and diarrhea and those who fulfi lled the Rome III criteria for IBS were also excluded. Patients using laxatives, tegaserod, or lubiprostone were asked to discontinue these medications at least 2 weeks before study.
We also recruited a control group of subjects referred to our tertiary care center for evaluation of unexplained abdominal pain, bloating, excessive fl atulence, or nausea, but without any history of constipation or diarrhea. Th is study was approved by the Institutional Review Board of the University of Iowa.
Protocol
All subjects maintained a prospective stool diary for 7 days. Information on stool frequency and stool consistency (Bristol Stool Scale) was recorded. On day 2 of the 7-day period, subjects ingested a Sitmarker capsule (see below) and the colon transit assessment was performed concurrently with the stool diary. Subsequently, about 1 -4 weeks later, subjects underwent a glucose breath test to evaluate the presence of methanogenic fl ora.
Colonic transit study . A single capsule containing 24 radioopaque markers (ROMs) (Sitzmarks; Konsyl Pharmaceuticals, Fort Worth, TX) was administered on day 1 and a plain abdominal X-ray was obtained on day 6 (120 h later) (13 -16) . Retention of ≥ 20 % markers ( ≥ 6 markers) on day 6 (120 h) was considered abnormal (16) and indicative of slow transit (ST) constipation.
Glucose breath test . All subjects underwent breath testing with glucose. One day before the test, subjects were asked to consume a carbohydrate restricted diet to avoid high baseline values of breath H 2 or CH 4 from ingestion of previously unabsorbed carbohydrates. No food or drink was allowed for at least 12 h before the study. A baseline breath sample was obtained and a solution of glucose (75 g in 250 ml water) was administered to the patient. End expiration breath samples were collected using a modifi ed (Haldane-Priestley) bag (Quin Tron, Milwaukee, WI) and analyzed for the concentration of H 2 and CH 4 using a gas chromatography analyzer (Quintron Microlyzer Self-Correcting Model SC, Quin Tron). Breath samples were collected at 15 min intervals for 2 h (17,18) .
Data analysis
Presence of methanogenic fl ora was defi ned as a baseline CH 4 value of at least 3 p.p.m. on two separate breath samples. Earlier studies (4) have used ≥ 1 p.p.m. to defi ne the presence of methanogenic fl ora; we chose a higher level to avoid any spurious levels from technical or mechanical errors.
Patients were categorized into two groups: (i) ST constipation ( ≥ 20 % retention of ROM at 120 h); (ii) normal transit (NT) constipation ( < 20 % retention of ROM at 120 h) .
Breath H 2 and CH 4 responses for each subject were analyzed for the following parameters: (i) baseline value (in p.p.m.); (ii) peak values (in p.p.m.); and (iii) area under the curve (AUC) (in p.p.m. h). For each subject, we examined the breath H 2 and CH 4 data obtained from the glucose breath test and used this as evidence for the presence of methanogenic fl ora.
Statistical analysis
Students ' t -test was used to compare the baseline, peak, and AUC of the breath H 2 and CH 4 responses among the controls, ST, and NT groups. Spearman test was used to correlate colonic transit ( % retention of markers at 120 h), stool frequency (BM / week), and stool consistency (Bristol Scale 1 -7) with breath CH 4 responses in each group. Correlation analysis was performed within the methane producers in each group. A P value < 0.05 was considered signifi cant. Next, multiple regression analyses were performed to evaluate for interaction between stool consistency, stool frequency, colonic transit, and methane values, in a combined sample of all methane-producing constipated subjects (ST and NT). Adjusted R 2 values were calculated for the correlation between methane values and stool characteristics and transit. We used a commercially available soft ware package (Prism 3.0 and InStat; GraphPad Soft ware, San Diego, CA) to facilitate statistical analysis.
RESULTS
Subject demographics and characteristics
We examined 96 patients (M / F = 7 / 89, mean age 47.4 years, range 21 -75 years) with CC and 106 non-constipated subjects (M / F = 36 / 70, mean age 55.4 years, range 21 -86 years). Th ere was no statistically signifi cant diff erence ( P >0.05) in the mean age but there were signifi cantly ( P < 0.05) more females in the constipated group compared to the non-constipated group.
In the constipated group, 48 subjects had normal colonic transit and 48 patients had slow colonic transit. Th ere was no signifi -
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cant diff erence ( P >0.05) in either the age or gender distribution between the NT and ST groups (mean age ± s.d.: 45.2 ± 24.5 years vs. 48.8 ± 26.6 years; M / F = 3 / 45 and 4 / 44, respectively).
Prevalence of methanogenic fl ora
We found that 30 / 106 (28 % ) controls had methanogenic fl ora, which is similar to the prevalence in the general population reported earlier (4, 5) . In the patient groups, 21 / 48 (44 % ) NT patients and 36 / 48 (75 % ) ST patients had methanogenic fl ora ( Figures 1 and 2 ) . Th e prevalence of methanogenic fl ora was signifi cantly higher ( P = 0.02) in the ST group, when compared with either the NT group or controls. Th e prevalence of methanogenic fl ora was similar ( P >0.05) in the NT group and controls. Furthermore, the baseline levels of methane (before administration of carbohydrate) were signifi cantly higher in the ST group when compared with the NT group and controls, respectively (mean ± s.d.: 23.1 ± 14.6 p.p.m. vs. 10.7 ± 6.1 p.p.m. vs. 13.5 ± 6.9 p.p.m., P = 0.01) ( Table 1 ) .
Methane production after administration of carbohydrate substrate
Methane production aft er administration of glucose may serve as a surrogate measure of methanogenic fl ora. Aft er administration of glucose, subjects in the ST group had signifi cantly higher methane response (peak levels and AUC) when compared to the NT group and controls ( P < 0.05) ( Table 1 ). H 2 production was higher ( P < 0.05) in the controls compared to the NT group and ST group, and there was no statistically signifi cant diff erence between the NT and ST groups.
Within methane producers in the ST and NT groups, to assess the correlation between level of methane production and constipation severity, we performed correlation analyses. Multiple linear regression analysis was performed, with methane levels as the dependent variables, and stool consistency, stool frequency, and colon transit as predictors. Th ere was a signifi cant overall relationship ( R 2 = 53.4 % for baseline methane, P < 0.0001) and colon transit was the only signifi cant contributor ( R 2 = 52.5 % , P < 0.0001), whereas stool consistency and stool frequency did not contribute signifi cantly to the model ( P >0.3) ( Table 2 ) .
Th e proportion of subjects with a positive glucose breath test ( ≥ 20 p.p.m. rise of methane and or hydrogen above baseline, in association with symptoms) was similar in controls (13 / 106; 12 % ), and the NT group (6 / 48, 12 % ), whereas the ST group had higher prevalence (17 / 48; 35 % ).
Stool characteristics
Th e prospective 7-day stool diary revealed no diff erences in the stool frequency / week in the ST and NT groups (4 / week and 4.8 / week, respectively, P >0.05). Similarly, there was no diff erence in mean stool consistency on the Bristol Stool Form Scale (2.8 in ST group, and 2.9 in NT group, respectively, P >0.05). Th erefore, although the groups had diff erent colonic transit times, there was no objective diff erence in the severity of constipation, as assessed by stool characteristics, between the two groups. Attaluri et al .
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DISCUSSION
In this study, we found that subjects with CC have higher prevalence of methanogenic flora when compared with nonconstipated subjects. Furthermore, the prevalence of methanogenic flora was higher in constipated patients with slower colonic transit than those with normal colonic transit. In response to a carbohydrate substrate, CH 4 production was higher in patients with slower transit than those with NT or controls. Moreover, among methane producers in the ST group, CH 4 production correlated with colonic transit, but not with stool consistency or stool frequency. Th erefore, these results show a qualitative correlation between CC and the presence of methanogenic fl ora, as well as a quantitative correlation between the degree of methane production and colonic transit. Interestingly, there was no relationship between methane production and some objective measures that are commonly used to grade the severity of constipation such as stool frequency and stool consistency. Earlier studies have reported a relationship among colonic transit, stool consistency, and stool frequency (4, 7, 10) . In a recent study, colonic transit in constipated patients correlated well with stool consistency but not with stool frequency (19) . It is unclear how many of these subjects had methanogenic fl ora. Methane increases non-propagating small bowel contractile activity and decrease small bowel transit in animal models (11) . On the basis of above data, the pathogenesis of methane-associated constipation is unclear; methane may have physiologic eff ects on both the small bowel and colon, which retards chyme transport.
We wish to emphasize that although this study suggests an association between methanogenesis and constipation, causality cannot be established on the basis of our data. However, prevalence of methanogenic fl ora and methane production were both higher in the ST group than in the NT group, despite no apparent diff erences in their stool frequency or stool consistency. On the basis of these data, one could speculate that methanogenic fl ora may predispose to slower colonic transit in patients with constipation. However, it is equally possible that higher levels of methanogenic fl ora may be a consequence, rather than a cause of ST constipation, and this merits further study.
Children with constipation and soiling have been shown to have a higher prevalence of methanogenic fl ora and relatively slower colonic transit (7) . Patients with IBS and methane production (aft er lactulose load) were also reported to invariably have IBS-C (8) . Our fi ndings are consistent with these studies in that we can confi rm a relationship between the presence of methanogenic fl ora and constipation. However, it is worth pointing out that 27 % of subjects with ST and 56 % of subjects with NT had non-methanogenic fl ora. Th us, the presence of methanogenic fl ora may be one of the predisposing factors for the development of constipation and many constipated patients have non-methanogenic fl ora. Moreover, there seems to be a trend toward higher hydrogen production in controls and NT subjects, probably because of lower conversion to methane by methanogenic fl ora (1) .
Our fi nding of an association between methanogenesis and slower colonic transit and the absence of an association with stool characteristics is intriguing and the reasons are unclear. We speculate that the underlying pathogenesis of ST constipation is diff erent from that of NT and that methane may have a more important function in ST constipation. Th e exact mechanisms require further study.
One of the limitations of our study was that glucose was used as the carbohydrate substrate. Although this substrate does not aff ect prevalence data, methane production aft er glucose primarily refl ects fermentation by small bowel fl ora and therefore does not accurately refl ect colonic methanogenic fl ora loads. A higher proportion of the ST patients had a positive glucose breath test compared to either the NT patients or controls, and this could partly explain increased methane production in this group. In addition, though the stool diary was maintained concurrently with the colon transit test, the breath test was performed at a later date.
It has been reported that treatment with neomycin improves constipation in IBS-C and that the improvement depends on the presence and elimination of methane as examined by a lactulose breath test (9) . Although these fi ndings are intriguing and may be true, it is debatable whether the improvement in symptoms was due to the elimination of methanogenic fl ora. Moreover, is it unclear whether colonic fl ora can be altered by antibiotics and whether such a change can be sustained in the long term. Nonetheless, our study provides further evidence for an association between methanogenesis and constipation, and in particular, the relationship between slower colonic transit and constipation. Whether these fi ndings are due to altered colonic microbiota merits further appraisal.
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